CVS Health Corporation Shares Purchased by Kiltearn Partners LLP

Institutional investor boosts stake in pharmacy operator CVS Health

Published on Mar. 9, 2026

Kiltearn Partners LLP, an institutional investor, increased its holdings in CVS Health Corporation (NYSE:CVS) by 1.6% during the third quarter, according to a recent SEC filing. Kiltearn Partners now owns 530,168 shares of the pharmacy operator's stock, valued at approximately $39.9 million, making CVS Health its second-largest holding.

Why it matters

This purchase by Kiltearn Partners, a major institutional investor, signals continued confidence in CVS Health's business and growth prospects. As a leading pharmacy and healthcare company, CVS Health's performance is closely watched by the investment community.

The details

According to the SEC filing, Kiltearn Partners LLP boosted its stake in CVS Health by adding 8,500 shares during the third quarter. This increased the firm's total holdings in CVS to 530,168 shares, which account for approximately 8% of Kiltearn Partners' investment portfolio.

  • Kiltearn Partners LLP increased its CVS Health holdings during the third quarter of 2026.

The players

Kiltearn Partners LLP

An institutional investment firm that has increased its stake in CVS Health Corporation.

CVS Health Corporation

A diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services, and health care solutions.

Got photos? Submit your photos here. ›

The takeaway

Kiltearn Partners' increased investment in CVS Health suggests the firm sees continued growth potential in the pharmacy and healthcare company, which could signal positive sentiment among institutional investors about CVS Health's future performance.